FORNI, Flavio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 36.774
EU - Europa 20.763
AS - Asia 16.529
SA - Sud America 2.273
AF - Africa 418
OC - Oceania 48
Continente sconosciuto - Info sul continente non disponibili 27
Totale 76.832
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 36.191
GB - Regno Unito 6.630
IT - Italia 4.790
SG - Singapore 4.596
CN - Cina 4.525
SE - Svezia 3.765
HK - Hong Kong 2.090
BR - Brasile 1.698
VN - Vietnam 1.670
DE - Germania 1.143
TR - Turchia 810
UA - Ucraina 801
FI - Finlandia 735
RU - Federazione Russa 709
FR - Francia 684
BD - Bangladesh 663
KR - Corea 544
IN - India 412
BG - Bulgaria 314
CA - Canada 279
NL - Olanda 204
AR - Argentina 179
MX - Messico 163
JP - Giappone 161
RO - Romania 151
IQ - Iraq 143
ZA - Sudafrica 132
IE - Irlanda 129
ID - Indonesia 128
ES - Italia 115
PL - Polonia 109
PK - Pakistan 98
BE - Belgio 94
EC - Ecuador 94
AE - Emirati Arabi Uniti 88
CO - Colombia 87
MY - Malesia 72
CH - Svizzera 66
VE - Venezuela 61
TH - Thailandia 60
CL - Cile 57
MA - Marocco 57
IR - Iran 52
DZ - Algeria 48
LT - Lituania 48
EG - Egitto 46
PH - Filippine 42
UZ - Uzbekistan 42
AU - Australia 40
SA - Arabia Saudita 40
CZ - Repubblica Ceca 37
IL - Israele 37
PT - Portogallo 37
JO - Giordania 36
NP - Nepal 36
PE - Perù 35
TN - Tunisia 34
PY - Paraguay 31
AT - Austria 28
KE - Kenya 27
TW - Taiwan 26
AZ - Azerbaigian 25
JM - Giamaica 25
GR - Grecia 23
EU - Europa 20
KZ - Kazakistan 20
SN - Senegal 19
DO - Repubblica Dominicana 17
ET - Etiopia 17
MD - Moldavia 17
BO - Bolivia 16
DK - Danimarca 16
AL - Albania 14
TT - Trinidad e Tobago 14
UY - Uruguay 14
CR - Costa Rica 13
LB - Libano 13
OM - Oman 13
BY - Bielorussia 12
RS - Serbia 12
HU - Ungheria 11
LV - Lettonia 10
NO - Norvegia 10
PA - Panama 10
GT - Guatemala 9
KG - Kirghizistan 9
NI - Nicaragua 9
EE - Estonia 8
HN - Honduras 8
HR - Croazia 8
NZ - Nuova Zelanda 8
BH - Bahrain 7
CY - Cipro 7
PR - Porto Rico 7
PS - Palestinian Territory 7
SI - Slovenia 7
SV - El Salvador 7
AM - Armenia 6
AO - Angola 6
KH - Cambogia 6
Totale 76.699
Salva come PNG Salva come JPEG
Città #
Southend 5.220
Santa Clara 3.434
Ashburn 3.393
Singapore 2.879
Fairfield 2.618
Chandler 2.172
Hong Kong 2.052
Woodbridge 1.903
Stockholm 1.816
Jacksonville 1.620
Hefei 1.444
Houston 1.328
Chicago 1.266
San Jose 1.231
Dearborn 1.215
Wilmington 1.108
Seattle 1.069
Nyköping 1.060
Ann Arbor 1.049
Beijing 890
Cambridge 883
Los Angeles 796
London 735
Council Bluffs 549
Ho Chi Minh City 542
Modena 486
Izmir 465
Seoul 462
Helsinki 441
The Dalles 440
Hanoi 398
New York 377
Milan 372
Salt Lake City 337
Princeton 324
Sofia 301
Eugene 276
Dallas 253
Des Moines 251
San Diego 239
Rome 232
Buffalo 231
Lauterbourg 231
Moscow 182
Redwood City 180
Shanghai 154
São Paulo 147
Bremen 146
Tampa 143
Elk Grove Village 135
Orem 133
Tokyo 120
Munich 118
Dublin 108
Fremont 104
Columbus 98
Bologna 97
Naples 95
Boardman 94
Frankfurt am Main 94
Phoenix 91
Chennai 86
Brussels 81
Falls Church 76
Guangzhou 76
Lancaster 76
Jakarta 70
Da Nang 69
Johannesburg 65
Sterling 65
Haiphong 62
Miami 62
Warsaw 61
Toronto 59
Florence 58
Parma 58
Washington 58
Brooklyn 57
Atlanta 56
Norwalk 54
Denver 53
Turin 53
Baghdad 50
Montreal 50
Como 49
Nanjing 48
Amsterdam 47
Dulles 47
Bari 46
Detroit 46
Miano 46
Kunming 45
Catania 44
Mexico City 44
Reggio Emilia 43
Rio de Janeiro 43
Mumbai 41
Belo Horizonte 40
Charlotte 40
Napoli 39
Totale 52.790
Salva come PNG Salva come JPEG
Nome #
A novel phytocannabinoid isolated from Cannabis sativa L. with an in vivo cannabimimetic activity higher than Δ9-tetrahydrocannabinol: Δ9-Tetrahydrocannabiphorol 2.321
AFM/TEM complementary structural analysis of surface-functionalized nanoparticles 597
Nanovettori lipidici e polimerici per la somministrazione sito-specifica di farmaci antitumorali 512
Analysis of cannabinoids in commercial hemp seed oil and decarboxylation kinetics studies of cannabidiolic acid (CBDA) 500
Can leptin-derived sequence-modified nanoparticles be suitable tools for brain delivery? 495
Cristallinità ed equivalenza nel cloramfenicolo palmitato 489
Targeting the Central Nervous System: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123 467
Nanoimaging: photophysical and pharmaceutical characterization of poly-lactide-co-glycolide nanoparticles engineered with quantum dots 464
Flow cytometry and live confocal analysis for the evaluation of the uptake and intracellular distribution of FITC-ODN into HaCaT cells 459
AFM, ESEM, TEM and CLSM in liposomal characterization: a comparative study 449
Exploiting Bacterial Pathways for BBB Crossing with PLGA Nanoparticles Modified with a Mutated Form of Diphtheria Toxin (CRM197): In Vivo Experiments 436
Development of a simple and sensitive liquid chromatography triple quadrupole mass spectrometry (LC–MS/MS) method for the determination of cannabidiol (CBD), Δ9-tetrahydrocannabinol (THC) and its metabolites in rat whole blood after oral administration of a single high dose of CBD 431
Cationic liposomes for gene transfection 424
NIR-labeled nanoparticles engineered for brain targeting: in vivo optical imaging application and fluorescent microscopy evidences. 422
Characterization of lysosome-destabilizing DOPE/PLGA nanoparticles designed for cytoplasmic drug release 421
Nanoparticulate drug carriers based on hybrid poly(D,L-lactide-co-glycolide)-dendron structures 421
NUTRASCIENCE s.r.l. 420
NANOPARTICELLE IBRIDE PLGA/DOPE: STUDI DI TRANSFEZIONE, ESCAPE ENDOSOMIALE E TRAFFICKING CELLULARE 419
Nanotechnology and Alzheimer’s disease: What has been done and what to do’ 416
Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution 408
Chemico-physical investigation of tenofovir loaded polymeric nanoparticles 408
PEG-g-chitosan nanoparticles functionalized with the monoclonal antibody OX26 for brain drug targeting 404
Apoferritin nanocage as streptomycin drug reservoir: Technological optimization of a new drug delivery system 400
Use of Polylactide-Co-Glycolide-Nanoparticles for Lysosomal Delivery of a Therapeutic Enzyme in Glycogenosis Type II Fibroblasts 399
Poly (D,L-lactide-co-glycolide) nanoparticles loaded with Cerebrolysin display neuroprotective activity in a rat model of closed head injury 397
Sialic Acid as a potential approach for the protection and targeting of nanocarriers 394
Collagen modified based membranes for tissue engineering: influence of type and molecular weight of GAGs on cell proliferation 388
Peptide-derivatized biodegradable nanoparticles able to cross the blood-brain barrier 385
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 380
AFM phase imaging of soft-hydrated samples: A versatile tool to complete the chemical-physical study of liposomes 376
Analysis of impurities of cannabidiol from hemp. Isolation, characterization and synthesis of cannabidibutol, the novel cannabidiol butyl analog 374
Polymeric nanoparticles for the drug delivery to the central nervous system 373
Nanoparticle transport across the blood brain barrier 370
Endocytosis of Nanomedicines: The Case of Glycopeptide Engineered PLGA Nanoparticles 370
Insight on the fate of CNS-targeted nanoparticles. Part II: Intercellular neuronal cell-to-cell transport 369
A Nanoparticle-based approach for drug delivery to the brain in Lysosomal Storage Disorders 366
Application of Polymeric Nanoparticles for CNS Targeted Zinc Delivery In Vivo 366
Current Strategies for the Delivery of Therapeutic Proteins and Enzymes to Treat Brain Disorders 363
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 363
Distribution of drugs in polymers loaded by swelling 362
Insight on the fate of CNS-targeted nanoparticles. Part I: Rab5-dependent cell-specific uptake and distribution 360
Protein corona and nanoparticles: How can we investigate on? 356
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 355
Isolation of a High-Affinity Cannabinoid for the Human CB1 Receptor from a Medicinal Cannabis sativa Variety: Δ9-Tetrahydrocannabutol, the Butyl Homologue of Δ9-Tetrahydrocannabinol 355
Flow Cytometry and live confocal analysis in the evaluation of uptake and intracellular distribution of FITC-ODN into HaCaT cells 350
Diffusione di derivati dell\'acido benzoico attraverso membrane lipidiche in presenza di Tween 80 350
Protein cage nanostructure as drug delivery system: magnifying glass on apoferritin 348
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 347
The loading of labeled antibody engineered nanoparticles with Indinavir increases its in vitro efficacy against Cryptosporidium parvum 346
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 346
Microwave-treated gelatin microspheres as drug delivery system 345
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 341
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 337
Biodisponibilità e bioequivalenza in compresse commerciali di nitrofurantoina 336
Reduced plaque size and inflammation in the APP23 mouse model for Alzheimer's disease after chronic application of polymeric nanoparticles for CNS targeted zinc delivery 336
The grinding of the polymorphic forms of chloramphenicol stearic ester in the presence of colloidal silica 335
PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury 334
AFM and TEM characterization of siRNAs lipoplexes: a combinatory tools to predict the efficacy of complexation 333
Investigation on Mechanisms of Glycopeptide Nanoparticles for Drug Delivery across the Blood-Brain Barrier 333
Peptide-engineered polylactide-co-glycolide (PLGA) nanoparticles for brain delivery of drugs: in vivo experiments and proof of concept 332
NANOMEDICINE IN NEUROSCIENCE: THE POTENTIAL OF TARGETED NANOPARTICLES IN NEURODEGENERATIVE DISORDERS 332
Qualitative and semiquantitative analysis of the protein coronas associated to different functionalized nanoparticles 332
Atomic force microscopy and photon correlation spectroscopy: Two techniques for rapid characterization of liposomes 332
NANOPARTICELLE POLIMERICHE PER LA VEICOLAZIONE DI MACROMOLECOLE PROTEICHE: STUDI PRELIMINARI DI CARATTERIZZAZIONE TECNOLOGICA 331
ROS-responsive “smart” polymeric conjugate: Synthesis, characterization and proof-of-concept study 330
Cannabinoid profiling of hemp seed oil by liquid chromatography coupled to high-resolution mass spectrometry 329
A theoretical model for the calculation of the drug distribution profile in matrices of different shape to achieve the desired drug release kinetics 328
Untargeted rat brain metabolomics after oral administration of a single high dose of cannabidiol 327
Conjugated poly(D,L-lactide-co-glycolide) for the preparation of in vivo detectable nanoparticles 327
How does “Protein Corona” Affect the In vivo Efficiency of Polymeric Nanoparticles? State of Art 325
Chemical and spectroscopic characterization data of ‘cannabidibutol’, a novel cannabidiol butyl analog 325
Identification of a new cannabidiol n-hexyl homolog in a medicinal cannabis variety with an antinociceptive activity in mice: cannabidihexol 325
Dotap/Udca vesicles: novel approach in oligonucleotide delivery 323
Glioblastoma: State of the Art of Treatments and Applications of Polymeric and Lipidic Nanomedicines 322
Development and characterization of biodegradable nanospheres as delivery systems of anti-ischemic adenosine derivatives 320
Nanoparticles engineered with rituximab and loaded with Nutlin-3 show promising therapeutic activity in B-leukemic xenografts. 319
Brain-targeted polymeric nanoparticles: In vivo evidence of different routes of administration in rodents 318
Cholesterol-loaded nanoparticles ameliorate synaptic and cognitive function in Huntington's disease mice 317
Development of novel Zn2+ loaded nanoparticles designed for cell-type targeted drug release in CNS neurons: in vitro evidences. 316
Liposome-oligonucleotides interaction for in vitro uptake by COSI and HaCaT cells 316
Brain targeting by engineered nanoparticles: in vivo and in vitro evidences 316
PLGA-PEG-ANG-2 Nanoparticles for Blood-Brain Barrier Crossing: Proof-of-Concept Study 313
Targeted polymeric nanoparticles for brain delivery of high molecular weight molecules in lysosomal storage disorders 311
Nanoparticles for brain delivery of drugs: in vivo experiments andmechanism of BBB crossing 309
Functionalization of liposomes: microscopical methods for preformulative screening 309
NANOPARTICELLE POLIMERICHE PER IL DIREZIONAMENTO CEREBRALE: DELIVERY DI ZINCO E STUDI PRELIMINARI IN VITRO SU CELLULE NEURONALI 307
Colloidal systems for CNS drug delivery 306
Potential Use of Nanomedicine for Drug Delivery Across the Blood-Brain Barrier in Healthy and Diseased Brain 306
Biodegradable device applied in flatfoot surgery: Comparative studies between clinical and technological aspects of removed screws 299
Pitfalls in the analysis of phytocannabinoids in cannabis inflorescence 299
EXPLOITING THE VERSATILITY OF CHOLESTEROL IN NANOPARTICLES FORMULATION 298
Acidi colici nella preparazione di liposomi cationici per la transfezione in cellule HaCaT 298
Applicazione delle tecniche microscopiche, spettroscopiche e calorimetriche nella caratterizzazione di nanoparticelle funzionalizzate 297
NANOPARTICELLE DIREZIONANTI AL CERVELLO: RIPRISTINO DEI LIVELLI DI COLESTEROLO CELLULARE NELLA TERAPIA DELLA COREA DI HUNTINGTON. 295
A solution and solid state study on 2-hydroxypropyl-beta-cyclodextrin complexation with hyodeoxycholic acid 291
AN INTERPRETATIVE ANALYSIS OF THE EFFECT OF THE SURFACTANTS USED FOR THE PREPARATION OF POLYALKYLCYANOACRYLATE NANOPARTICLES ON THE RELEASE PROCESS 291
Pseudomorfosi nel cloramfenicolo stearato e palmitato in relazione alla disponibilità 291
Solid state transitions and CAP availability in surface solid dispersions of chloramphenicol stearate polymorphs 290
Activitè enzymatique de la pancréatine de formes pharmaceutiques: une nouvelle méthode d'évaluation 288
Glycopeptide-decorated nanoparticles as drug carriers for CNS: effects of surface coverage and carbohydrate type 287
Totale 37.948
Salva come PNG Salva come JPEG
Categoria #
all - tutte 276.659
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 276.659
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20225.275 221 631 486 430 173 261 274 296 604 387 871 641
2022/20236.271 749 683 534 609 764 980 160 525 673 96 225 273
2023/20243.890 185 227 226 295 816 391 468 527 138 118 173 326
2024/202512.486 647 183 264 943 2.567 1.738 895 819 1.177 476 1.302 1.475
2025/202624.442 1.437 785 1.782 2.776 4.171 1.590 2.383 1.060 4.114 2.108 1.245 991
2026/2027442 442 0 0 0 0 0 0 0 0 0 0 0
Totale 77.273